Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016

What is the link between mechanobiology and cancer?

Prof Michael Sheetz - National University of Singapore and Columbia University
What is the link between mechanobiology and cancer? ( Prof Michael Sheetz - National University of Singapore and Columbia University )
11 Jan 2016

How does your garden grow? For cancer patients, small gardens could bring big benefits

Dr Ceri Phelps - University of Wales Trinity Saint David, UK
How does your garden grow? For cancer patients, small gardens could bring big benefits ( Dr Ceri Phelps - University of Wales Trinity Saint David, UK )
11 Jan 2016

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer

Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016

Molecular genetics of testicular cancer: What does the clinician need to know?

Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016

Regular aspirin use may reduce risk of dying from prostate cancer

Dr Christophe Allard - Massachusetts General Hospital, Boston, USA
Regular aspirin use may reduce risk of dying from prostate cancer ( Dr Christophe Allard - Massachusetts General Hospital, Boston, USA )
8 Jan 2016

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
7 Jan 2016

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours

Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016

Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer

Dr Yifat Merbl – Weizmann Institute of Science, Rehovot, Israel
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer ( Dr Yifat Merbl – Weizmann Institute of Science, Rehovot, Israel )
4 Jan 2016

Medical cancer prevention

Dr Bernardo Bonanni - European Institute Of Oncology, Milan, Italy
Medical cancer prevention ( Dr Bernardo Bonanni - European Institute Of Oncology, Milan, Italy )
22 Dec 2015